MV Lifesciences

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte : STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), DEMISSIONS, NOMINATIONS, CAPITAL, ACTIONS",
      "value": "STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), DEMISSIONS, NOMINATIONS, CAPITAL, ACTIONS",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-31",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 31/07/2026 - Annexes du Moniteur belge",
      "value": "31/07/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-29",
      "type": "filing",
      "quote": "D\u00E9pos\u00E9 29-07-2026",
      "value": "29-07-2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-13",
      "type": "notarial_deed",
      "quote": "Ce jour, le treize juillet deux mille vingt-six. Devant Tim CARNEWAL, notaire \u00E0 Bruxelles",
      "value": "13/07/2026",
      "object": "e2",
      "subject": "e1"
    },
    {
      "date": "2026-07-13",
      "type": "general_meeting",
      "quote": "Ce jour, le treize juillet deux mille vingt-six. (...) S\u2019EST REUNIE L\u2019assembl\u00E9e g\u00E9n\u00E9rale extraordinaire",
      "value": "13/07/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "capital_increase",
      "quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de 177.421,67 EUR, pour le porter de 61.500,00 \u00E0 238.921,67 EUR, par l\u0027\u00E9mission de 23.737 actions... par l\u2019apport par les Apporteurs... de cr\u00E9ances",
      "value": {
        "after": "238.921,67 EUR",
        "delta": "177.421,67 EUR",
        "amount": 238921.67,
        "before": "61.500,00 EUR",
        "method": "apport en nature (cr\u00E9ances)",
        "premium": "15.603.107,91 EUR",
        "currency": "EUR",
        "shares_issued": 23737
      },
      "amount": 177421.67,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": {
        "after": "238.921,67 EUR",
        "delta": "177.421,67 EUR",
        "before": "61.500,00 EUR",
        "method": "apport en nature (cr\u00E9ances)",
        "premium": "15.603.107,91 EUR",
        "shares_issued": 23737
      }
    },
    {
      "type": "capital_increase",
      "quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 une deuxi\u00E8me fois \u00E0 concurrence de 24.581.641,16 EUR, pour le porter de 238.921,67 EUR \u00E0 24.820.562,83 EUR, par incorporation au capital du montant total de la prime d\u0027\u00E9mission... et sans \u00E9mission de nouvelles actions.",
      "value": {
        "after": "24.820.562,83 EUR",
        "delta": "24.581.641,16 EUR",
        "amount": 24820562.83,
        "before": "238.921,67 EUR",
        "method": "incorporation du compte Primes d\u0027\u00E9mission",
        "currency": "EUR",
        "shares_issued": 0
      },
      "amount": 24581641.16,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": {
        "after": "24.820.562,83 EUR",
        "delta": "24.581.641,16 EUR",
        "before": "238.921,67 EUR",
        "method": "incorporation du compte Primes d\u0027\u00E9mission",
        "shares_issued": 0
      }
    },
    {
      "type": "capital_increase",
      "quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de 10.000.000,00 EUR, pour le porter de 24.820.562,83 EUR \u00E0 34.820.562,83 EUR... par apport en num\u00E9raire et par l\u2019 \u00E9mission de 12.787 actions... lib\u00E9r\u00E9es \u00E0 concurrence de 96,25%",
      "value": {
        "after": "34.820.562,83 EUR",
        "delta": "10.000.000,00 EUR",
        "amount": 34820562.83,
        "before": "24.820.562,83 EUR",
        "method": "apport en num\u00E9raire",
        "currency": "EUR",
        "liberation": "96,25%",
        "shares_issued": 12787,
        "price_per_share": "782,04 EUR"
      },
      "amount": 10000000.0,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": {
        "after": "34.820.562,83 EUR",
        "delta": "10.000.000,00 EUR",
        "before": "24.820.562,83 EUR",
        "method": "apport en num\u00E9raire",
        "liberation": "96,25%",
        "shares_issued": 12787,
        "price_per_share": "782,04 EUR"
      }
    },
    {
      "type": "capital_decrease",
      "quote": "L\u0027assembl\u00E9e d\u00E9cide de r\u00E9duire le capital par apurement des pertes subies... \u00E0 concurrence de 24.101.436,61 EUR, pour le ramener de 34.820.562,83 EUR \u00E0 10.719.126,22 EUR, sans annulation d\u0027actions.",
      "value": {
        "after": "10.719.126,22 EUR",
        "delta": "24.101.436,61 EUR",
        "amount": 10719126.22,
        "before": "34.820.562,83 EUR",
        "method": "apurement des pertes",
        "currency": "EUR",
        "shares_cancelled": false
      },
      "amount": 24101436.61,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": {
        "after": "10.719.126,22 EUR",
        "delta": "24.101.436,61 EUR",
        "before": "34.820.562,83 EUR",
        "method": "apurement des pertes",
        "shares_cancelled": false
      }
    },
    {
      "type": "capital",
      "quote": "ARTICLE 5 : CAPITAL Le capital est fix\u00E9 \u00E0 dix millions sept cent dix-neuf mille cent vingt-six euros vingt-deux cents (\u20AC 10.719.126,22). Il est repr\u00E9sent\u00E9 par quarante-quatre mille sept cent cinquante-deux (44.752) actions",
      "value": {
        "amount": 10719126.22,
        "shares": 44752,
        "currency": "EUR"
      },
      "amount": 10719126.22,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": {
        "amount": "10.719.126,22 EUR",
        "shares": 44752
      }
    },
    {
      "type": "share_issue",
      "quote": "SEIZI\u00C8ME RESOLUTION: Emission de 42 Droits de Souscription Anti-Dilutifs.",
      "value": {
        "type": "Droits de Souscription Anti-Dilutifs",
        "count": 42
      },
      "object": null,
      "subject": "e1"
    },
    {
      "type": "share_issue",
      "quote": "VINGTI\u00C8ME RESOLUTION: Emission de 5.479 Droits de Souscription ESOP.",
      "value": {
        "type": "Droits de Souscription ESOP",
        "count": 5479
      },
      "object": null,
      "subject": "e1"
    },
    {
      "type": "purpose",
      "quote": "ARTICLE 3 : OBJET La soci\u00E9t\u00E9 a pour objet tant en Belgique qu\u0027\u00E0 l\u0027\u00E9tranger...",
      "value": "La soci\u00E9t\u00E9 a pour objet tant en Belgique qu\u0027\u00E0 l\u0027\u00E9tranger pour compte propre ou pour compte de tiers ou en participation avec des tiers 1. la recherche, l\u0027\u00E9tude, la conception, la r\u00E9alisation, la fabrication, la mise au point de mat\u00E9riel endoscopique, de diagnostic, th\u00E9rapeutique et autres; 2. le d\u00E9veloppement l\u0027\u00E9tude, la conception, la r\u00E9alisation et la fabrication de logiciels permettant l\u2019 exploitation des m\u00E9thodes sub 1 ainsi que de logiciels destin\u00E9s \u00E0 la recherche clinique; 3. la production, la promotion, l\u0027achat et la vente, la sous-traitance, l\u0027importation, l\u0027exportation en gros, demi-gros ou en d\u00E9tail, la repr\u00E9sentation et la maintenance dans les domaines cit\u00E9s sub 1 et 2 ainsi que d\u2019une mani\u00E8re g\u00E9n\u00E9rale de tout mat\u00E9riel m\u00E9dical; 4. la consultance, le parrainage et le partenariat dans les objets qui pr\u00E9c\u00E8dent; 5. le d\u00E9p\u00F4t et l\u0027exploitation des brevets, dessins et mod\u00E8les, marques et autres droits intellectuels et patrimoniaux issus des objets qui pr\u00E9c\u00E8dent; 6. La formation, l\u2019information, la publication et l\u2019\u00E9dition sur tous supports en relation avec les objets qui pr\u00E9c\u00E8dent. Dans le cadre du d\u00E9veloppement de formations individuelles et collectives, l\u0027organisation et l\u0027animation de stages et de s\u00E9minaires et la participation \u00E0 des conf\u00E9rences, des cours, et les journ\u00E9es d\u0027\u00E9tude concernant les objets qui pr\u00E9c\u00E8dent ; ces stages, s\u00E9minaires, conf\u00E9rences, cours et \u00E9tudes pouvant \u00EAtre organis\u00E9s \u00E0 l\u0027\u00E9tranger. 7. La recherche, l\u2019\u00E9tude, la conception, l\u2019achat et la vente de tous types d\u2019appareillages et accessoires n\u00E9cessaires \u00E0 la fabrication, la transformation, la conservation et l\u2019utilisation de ces produits. La soci\u00E9t\u00E9 peut pourvoir \u00E0 l\u0027administration, \u00E0 la supervision et au contr\u00F4le de toutes soci\u00E9t\u00E9s li\u00E9es ou avec lesquelles il existe un lien de participation et toutes autres, et consentir tous pr\u00EAts ou garanties \u00E0 celles-ci, sous quelque forme et pour quelque dur\u00E9e que ce soit. La soci\u00E9t\u00E9 peut accomplir toutes op\u00E9rations g\u00E9n\u00E9ralement quelconques, commerciales, industrielles, financi\u00E8res, mobili\u00E8res ou immobili\u00E8res, se rapportant directement ou indirectement \u00E0 son objet. Elle peut s\u0027int\u00E9resser par voie d\u0027apport, de souscription, de prise de participation, de fusion, ou toute autre forme d\u0027investissement en titres ou droits mobiliers, dans toutes affaires, entreprises, fondations, associations ou soci\u00E9t\u00E9s ayant un objet identique, analogue, similaire ou connexe, ou qui sont de nature \u00E0 favoriser le d\u00E9veloppement de son entreprise, \u00E0 lui procurer des mati\u00E8res premi\u00E8res ou \u00E0 faciliter l\u2019\u00E9coulement de ses produits. De mani\u00E8re g\u00E9n\u00E9rale, la soci\u00E9t\u00E9 peut r\u00E9aliser son objet directement ou indirectement et notamment conclure toute convention d\u0027association, de rationalisation, de collaboration, tout contrat de travail ou d\u0027entreprise, pr\u00EAter son concours financier sous quelque forme que ce soit, ex\u00E9cuter tous travaux et \u00E9tude pour toute entreprise, association ou soci\u00E9t\u00E9 \u00E0 laquelle elle se sera int\u00E9ress\u00E9e ou \u00E0 laquelle elle aura apport\u00E9 son concours financier, vendre, acheter, cautionner, donner \u00E0 bail ou prendre en location tout bien corporel ou incorporel, mobilier ou immobilier, donner \u00E0 bail ou affermer tout ou partie de ses installations, exploitations et son fonds de commerce.",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-13",
      "type": "officer_resignation",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de mettre fin au mandat des administrateurs non-statutaires suivants... La soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u0027\u0027DG International Consulting\u0027\u0027... \u00E0 partir de ce jour",
      "value": {
        "date": "2026-07-13",
        "role": "administrateur non-statutaire"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "date": "13/07/2026",
        "role": "administrateur non-statutaire"
      }
    },
    {
      "date": "2026-07-13",
      "type": "officer_resignation",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de mettre fin au mandat des administrateurs non-statutaires suivants... Monsieur CHAU Alexandre... \u00E0 partir de ce jour",
      "value": {
        "date": "2026-07-13",
        "role": "administrateur non-statutaire"
      },
      "object": "e1",
      "subject": "e8",
      "_value_raw": {
        "date": "13/07/2026",
        "role": "administrateur non-statutaire"
      }
    },
    {
      "date": "2026-07-13",
      "type": "officer_resignation",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de mettre fin au mandat des administrateurs non-statutaires suivants... Monsieur NOLET DE BRAUWERE VAN STEENLAND Marc Emmanuel... \u00E0 partir de ce jour",
      "value": {
        "date": "2026-07-13",
        "role": "administrateur non-statutaire"
      },
      "object": "e1",
      "subject": "e9",
      "_value_raw": {
        "date": "13/07/2026",
        "role": "administrateur non-statutaire"
      }
    },
    {
      "date": "2026-07-13",
      "type": "officer_resignation",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de mettre fin au mandat des administrateurs non-statutaires suivants... La soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u0027\u0027Mercury Leadership and Management\u0027\u0027... \u00E0 partir de ce jour",
      "value": {
        "date": "2026-07-13",
        "role": "administrateur non-statutaire"
      },
      "object": "e1",
      "subject": "e10",
      "_value_raw": {
        "date": "13/07/2026",
        "role": "administrateur non-statutaire"
      }
    },
    {
      "date": "2026-07-13",
      "type": "officer_resignation",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de mettre fin au mandat des administrateurs non-statutaires suivants... La soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u0027\u0027Old Mill Invest\u0027\u0027... \u00E0 partir de ce jour",
      "value": {
        "date": "2026-07-13",
        "role": "administrateur non-statutaire"
      },
      "object": "e1",
      "subject": "e12",
      "_value_raw": {
        "date": "13/07/2026",
        "role": "administrateur non-statutaire"
      }
    },
    {
      "date": "2026-07-13",
      "type": "officer_resignation",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de mettre fin au mandat des administrateurs non-statutaires suivants... La soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u0027\u0027Endomundi\u0027\u0027... \u00E0 partir de ce jour",
      "value": {
        "date": "2026-07-13",
        "role": "administrateur non-statutaire"
      },
      "object": "e1",
      "subject": "e14",
      "_value_raw": {
        "date": "13/07/2026",
        "role": "administrateur non-statutaire"
      }
    },
    {
      "date": "2026-07-13",
      "type": "officer_resignation",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de mettre fin au mandat des administrateurs non-statutaires suivants... La soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u0027\u0027MV Lifesciences\u0027\u0027... \u00E0 partir de ce jour",
      "value": {
        "date": "2026-07-13",
        "role": "administrateur non-statutaire"
      },
      "object": "e1",
      "subject": "e16",
      "_value_raw": {
        "date": "13/07/2026",
        "role": "administrateur non-statutaire"
      }
    },
    {
      "date": "2026-07-13",
      "type": "officer_resignation",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de mettre fin au mandat des administrateurs non-statutaires suivants... La soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u0027\u0027ODMC\u0027\u0027... \u00E0 partir de ce jour",
      "value": {
        "date": "2026-07-13",
        "role": "administrateur non-statutaire"
      },
      "object": "e1",
      "subject": "e18",
      "_value_raw": {
        "date": "13/07/2026",
        "role": "administrateur non-statutaire"
      }
    },
    {
      "date": "2026-07-13",
      "type": "officer_appointment",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer les personnes suivantes en tant qu\u2019administrateurs non-statutaires... Monsieur DUFF Eugene Joseph Alexander... \u00E0 partir de ce jour",
      "value": {
        "role": "administrateur non-statutaire",
        "term": "\u00E0 l\u2019issue de l\u2019assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u2019an 2029",
        "start_date": "2026-07-13"
      },
      "object": "e1",
      "subject": "e20",
      "_value_raw": {
        "role": "administrateur non-statutaire",
        "term": "\u00E0 l\u2019issue de l\u2019assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u2019an 2029",
        "start_date": "13/07/2026"
      }
    },
    {
      "date": "2026-07-13",
      "type": "officer_appointment",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer les personnes suivantes en tant qu\u2019administrateurs non-statutaires... La soci\u00E9t\u00E9 anonyme \u0022Capricorn Partners\u0022... \u00E0 partir de ce jour",
      "value": {
        "role": "administrateur non-statutaire",
        "term": "\u00E0 l\u2019issue de l\u2019assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u2019an 2029",
        "start_date": "2026-07-13"
      },
      "object": "e1",
      "subject": "e21",
      "_value_raw": {
        "role": "administrateur non-statutaire",
        "term": "\u00E0 l\u2019issue de l\u2019assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u2019an 2029",
        "start_date": "13/07/2026"
      }
    },
    {
      "date": "2026-07-13",
      "type": "officer_appointment",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer les personnes suivantes en tant qu\u2019administrateurs non-statutaires... Monsieur NOLET DE BRAUWERE Marc... \u00E0 partir de ce jour",
      "value": {
        "role": "administrateur non-statutaire",
        "term": "\u00E0 l\u2019issue de l\u2019assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u2019an 2029",
        "start_date": "2026-07-13"
      },
      "object": "e1",
      "subject": "e23",
      "_value_raw": {
        "role": "administrateur non-statutaire",
        "term": "\u00E0 l\u2019issue de l\u2019assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u2019an 2029",
        "start_date": "13/07/2026"
      }
    },
    {
      "date": "2026-07-13",
      "type": "officer_appointment",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer les personnes suivantes en tant qu\u2019administrateurs non-statutaires... La soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u0022Lumine Capital Advisors\u0022... \u00E0 partir de ce jour",
      "value": {
        "role": "administrateur non-statutaire",
        "term": "\u00E0 l\u2019issue de l\u2019assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u2019an 2029",
        "start_date": "2026-07-13"
      },
      "object": "e1",
      "subject": "e24",
      "_value_raw": {
        "role": "administrateur non-statutaire",
        "term": "\u00E0 l\u2019issue de l\u2019assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u2019an 2029",
        "start_date": "13/07/2026"
      }
    },
    {
      "date": "2026-07-13",
      "type": "officer_appointment",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer les personnes suivantes en tant qu\u2019administrateurs non-statutaires... La soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u0022DG International Consulting\u0022... \u00E0 partir de ce jour",
      "value": {
        "role": "administrateur non-statutaire",
        "term": "\u00E0 l\u2019issue de l\u2019assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u2019an 2029",
        "start_date": "2026-07-13"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "role": "administrateur non-statutaire",
        "term": "\u00E0 l\u2019issue de l\u2019assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u2019an 2029",
        "start_date": "13/07/2026"
      }
    },
    {
      "date": "2026-07-13",
      "type": "officer_appointment",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer les personnes suivantes en tant qu\u2019administrateurs non-statutaires... La soci\u00E9t\u00E9 anonyme \u0022SFPIM\u0022... \u00E0 partir de ce jour",
      "value": {
        "role": "administrateur non-statutaire",
        "term": "\u00E0 l\u2019issue de l\u2019assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u2019an 2029",
        "start_date": "2026-07-13"
      },
      "object": "e1",
      "subject": "e25",
      "_value_raw": {
        "role": "administrateur non-statutaire",
        "term": "\u00E0 l\u2019issue de l\u2019assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u2019an 2029",
        "start_date": "13/07/2026"
      }
    },
    {
      "type": "permanent_representative",
      "quote": "DG International Consulting... repr\u00E9sent\u00E9e de mani\u00E8re permanente par Monsieur GESTIN Denis",
      "value": null,
      "object": "e6",
      "subject": "e7"
    },
    {
      "type": "permanent_representative",
      "quote": "Mercury Leadership and Management... repr\u00E9sent\u00E9e de mani\u00E8re permanente par Monsieur DEGEER Philippe",
      "value": null,
      "object": "e10",
      "subject": "e11"
    },
    {
      "type": "permanent_representative",
      "quote": "Old Mill Invest... repr\u00E9sent\u00E9e de mani\u00E8re permanente par Monsieur BOCQUET Matthieu",
      "value": null,
      "object": "e12",
      "subject": "e13"
    },
    {
      "type": "permanent_representative",
      "quote": "Endomundi... repr\u00E9sent\u00E9e de mani\u00E8re permanente par Monsieur HUBERTY Vincent Louis Paul",
      "value": null,
      "object": "e14",
      "subject": "e15"
    },
    {
      "type": "permanent_representative",
      "quote": "MV Lifesciences... repr\u00E9sent\u00E9e de mani\u00E8re permanente par Monsieur VANBRABANT Michel Roger Emmanuel",
      "value": null,
      "object": "e16",
      "subject": "e17"
    },
    {
      "type": "permanent_representative",
      "quote": "ODMC... repr\u00E9sent\u00E9e de mani\u00E8re permanente par Monsieur DELPORTE Olivier",
      "value": null,
      "object": "e18",
      "subject": "e19"
    },
    {
      "type": "permanent_representative",
      "quote": "Capricorn Partners... repr\u00E9sent\u00E9e de mani\u00E8re permanente par Monsieur PINTELON Filip Geert Johan Dominiek",
      "value": null,
      "object": "e21",
      "subject": "e22"
    },
    {
      "type": "permanent_representative",
      "quote": "Lumine Capital Advisors... repr\u00E9sent\u00E9e de mani\u00E8re permanente par Monsieur BOCQUET Matthieu",
      "value": null,
      "object": "e24",
      "subject": "e13"
    },
    {
      "type": "permanent_representative",
      "quote": "DG International Consulting... repr\u00E9sent\u00E9e de mani\u00E8re permanente par Monsieur GESTIN Denis",
      "value": null,
      "object": "e6",
      "subject": "e7"
    },
    {
      "type": "permanent_representative",
      "quote": "SFPIM... repr\u00E9sent\u00E9e de mani\u00E8re permanente par Madame PHILIPPE Isabelle Fran\u00E7oise Marie Serge",
      "value": null,
      "object": "e25",
      "subject": "e26"
    },
    {
      "type": "filing_representative",
      "quote": "L\u0027assembl\u00E9e conf\u00E8re tous pouvoirs \u00E0 tout avocat ou collaborateur du cabinet d\u2019avocats Osborne Clarke... afin d\u0027assurer les formalit\u00E9s aupr\u00E8s d\u0027un guichet d\u2019entreprise...",
      "value": "formalit\u00E9s aupr\u00E8s d\u0027un guichet d\u2019entreprise... Banque Carrefour des Entreprises... Administration de la Taxe sur la Valeur Ajout\u00E9e",
      "object": "e1",
      "subject": "e27"
    },
    {
      "type": "share_class_suppression",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de supprimer toutes les classes d\u2019actions existantes de la Soci\u00E9t\u00E9, \u00E0 savoir la classe d\u2019actions A, la classe d\u2019actions B, la classe d\u2019actions C et la classe d\u2019actions D.",
      "value": "classe d\u2019actions A, classe d\u2019actions B, classe d\u2019actions C, classe d\u2019actions D",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "capital_increase",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide - sous la condition suspensive et dans la mesure de l\u0027exercice de tout ou partie des Droits de Souscription Anti-Dilutifs - de proc\u00E9der \u00E0 une augmentation de capital en num\u00E9raire d\u0027un montant maximum \u00E9gal \u00E0 la multiplication du nombre de droits de souscription anti-dilutifs exerc\u00E9s par le prix d\u0027exercice de ces Droits de Souscription Anti-Dilutifs, avec \u00E9ventuellement une inscription sur le compte \u0022primes d\u2019\u00E9mission\u0022 si le prix d\u0027exercice exc\u00E8de le pair comptable des actions au moment de leur \u00E9mission, et \u00E0 l\u0027\u00E9mission d\u0027un nombre d\u0027actions qui jouiront des m\u00EAmes droits et avantages que les actions existantes, tel qu\u2019indiqu\u00E9 dans les modalit\u00E9s d\u0027\u00E9mission et conditions d\u0027exercice des Droits de Souscription Anti-Dilutifs.",
      "value": {
        "method": "apport en num\u00E9raire",
        "currency": "EUR",
        "condition": "exercice des Droits de Souscription Anti-Dilutifs",
        "max_amount": "multiplication du nombre de droits exerc\u00E9s par le prix d\u0027exercice"
      },
      "object": null,
      "subject": "e1",
      "_value_raw": {
        "method": "apport en num\u00E9raire",
        "condition": "exercice des Droits de Souscription Anti-Dilutifs",
        "max_amount": "multiplication du nombre de droits exerc\u00E9s par le prix d\u0027exercice"
      }
    },
    {
      "type": "capital_increase",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide - sous la condition suspensive et dans la mesure de l\u0027exercice de tout ou partie des Droits de Souscription ESOP - de proc\u00E9der \u00E0 une augmentation de capital en num\u00E9raire d\u0027un montant maximum \u00E9gal \u00E0 la multiplication du nombre de Droits de Souscription ESOP exerc\u00E9s par le prix d\u0027exercice de ces Droits de Souscription ESOP, avec \u00E9ventuellement une inscription sur le compte \u0022primes d\u2019\u00E9mission\u0022 si le prix d\u0027exercice exc\u00E8de le pair comptable des actions au moment de leur \u00E9mission, et avec \u00E9mission d\u0027un nombre d\u0027actions de m\u00EAme nature et qui jouiront des m\u00EAmes droits et avantages que les actions existantes, tel qu\u2019indiqu\u00E9 dans les modalit\u00E9s d\u0027\u00E9mission et conditions d\u0027exercice des Droits de Souscription ESOP.",
      "value": {
        "method": "apport en num\u00E9raire",
        "currency": "EUR",
        "condition": "exercice des Droits de Souscription ESOP",
        "max_amount": "multiplication du nombre de droits exerc\u00E9s par le prix d\u0027exercice"
      },
      "object": null,
      "subject": "e1",
      "_value_raw": {
        "method": "apport en num\u00E9raire",
        "condition": "exercice des Droits de Souscription ESOP",
        "max_amount": "multiplication du nombre de droits exerc\u00E9s par le prix d\u0027exercice"
      }
    },
    {
      "type": "preemptive_rights_waiver",
      "quote": "ONZI\u00C8ME RESOLUTION: Renonciation au droit de souscription pr\u00E9f\u00E9rentielle. (...) DIX-SEPTI\u00C8ME RESOLUTION: Renonciation au droit de souscription pr\u00E9f\u00E9rentielle. (...) VINGT ET UNI\u00C8ME RESOLUTION: Renonciation au droit de souscription pr\u00E9f\u00E9rentielle.",
      "value": "ONZI\u00C8ME, DIX-SEPTI\u00C8ME et VINGT ET UNI\u00C8ME R\u00C9SOLUTIONS",
      "object": null,
      "subject": "e1"
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 39691,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0807.570.233",
      "kind": "company",
      "name": "ENDO TOOLS THERAPEUTICS",
      "attrs": {
        "seat": "Rue Cl\u00E9ment Ader 10, 6041 Charleroi",
        "legal_form": "Soci\u00E9t\u00E9 anonyme",
        "short_name": "ETT"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Tim CARNEWAL",
      "attrs": {}
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "org",
      "name": "BERQUIN NOTAIRES",
      "attrs": {
        "seat": "1000 Bruxelles, Avenue Lloyd George 11"
      }
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "company",
      "name": "Deloitte R\u00E9viseurs d\u2019Entreprises",
      "attrs": {
        "seat": "1930 Zaventem, Luchthaven Brussel Nationaal 1J, Gateway Building",
        "legal_form": "soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
      }
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "DELFORGE Julie",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": "0696.833.152",
      "kind": "company",
      "name": "DG International Consulting",
      "attrs": {
        "seat": "1180 Uccle, Avenue Fond\u2019Roy 128",
        "legal_form": "soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
      }
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "GESTIN Denis",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "CHAU Alexandre",
      "attrs": {}
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "NOLET DE BRAUWERE VAN STEENLAND Marc Emmanuel",
      "attrs": {
        "birth_date": "1957-03-22",
        "birth_place": "Bruxelles"
      }
    },
    {
      "id": "e10",
      "kbo": "0640.709.051",
      "kind": "company",
      "name": "Mercury Leadership and Management",
      "attrs": {
        "seat": "4031 Li\u00E8ge, Sart aux Fraises 2",
        "legal_form": "soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
      }
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "DEGEER Philippe",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": "0676.902.919",
      "kind": "company",
      "name": "Old Mill Invest",
      "attrs": {
        "seat": "1180 Uccle, Vallon d\u2019Ohain 11",
        "legal_form": "soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
      }
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "BOCQUET Matthieu",
      "attrs": {
        "birth_date": "1979-09-20",
        "birth_place": "Anderlecht"
      }
    },
    {
      "id": "e14",
      "kbo": "0736.382.131",
      "kind": "company",
      "name": "Endomundi",
      "attrs": {
        "seat": "1180 Uccle, Avenue de Messidor 336 bo\u00EEte 13",
        "legal_form": "soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
      }
    },
    {
      "id": "e15",
      "kbo": null,
      "kind": "person",
      "name": "HUBERTY Vincent Louis Paul",
      "attrs": {
        "birth_date": "1979-09-26",
        "birth_place": "Uccle"
      }
    },
    {
      "id": "e16",
      "kbo": "0781.705.776",
      "kind": "company",
      "name": "MV Lifesciences",
      "attrs": {
        "seat": "1331 Rixensart, Rue de Genval 22",
        "legal_form": "soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
      }
    },
    {
      "id": "e17",
      "kbo": null,
      "kind": "person",
      "name": "VANBRABANT Michel Roger Emmanuel",
      "attrs": {
        "birth_date": "1968-01-08",
        "birth_place": "Uccle"
      }
    },
    {
      "id": "e18",
      "kbo": "0897.279.989",
      "kind": "company",
      "name": "ODMC",
      "attrs": {
        "seat": "3090 Overijse, Kapucijnendreef 62",
        "legal_form": "soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
      }
    },
    {
      "id": "e19",
      "kbo": null,
      "kind": "person",
      "name": "DELPORTE Olivier",
      "attrs": {}
    },
    {
      "id": "e20",
      "kbo": null,
      "kind": "person",
      "name": "DUFF Eugene Joseph Alexander",
      "attrs": {
        "birth_date": "1988-09-18",
        "birth_place": "Londres (Royaume-Uni)"
      }
    },
    {
      "id": "e21",
      "kbo": "0449.330.922",
      "kind": "company",
      "name": "Capricorn Partners",
      "attrs": {
        "seat": "3000 Leuven, Lei 19 bo\u00EEte 1",
        "legal_form": "soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e22",
      "kbo": null,
      "kind": "person",
      "name": "PINTELON Filip Geert Johan Dominiek",
      "attrs": {
        "birth_date": "1964-01-24",
        "birth_place": "Brugge"
      }
    },
    {
      "id": "e23",
      "kbo": null,
      "kind": "person",
      "name": "NOLET DE BRAUWERE Marc",
      "attrs": {}
    },
    {
      "id": "e24",
      "kbo": null,
      "kind": "company",
      "name": "Lumine Capital Advisors",
      "attrs": {
        "legal_form": "soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
      }
    },
    {
      "id": "e25",
      "kbo": null,
      "kind": "company",
      "name": "SFPIM",
      "attrs": {
        "legal_form": "soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e26",
      "kbo": null,
      "kind": "person",
      "name": "PHILIPPE Isabelle Fran\u00E7oise Marie Serge",
      "attrs": {
        "birth_date": "1970-09-15",
        "birth_place": "Ottignies"
      }
    },
    {
      "id": "e27",
      "kbo": null,
      "kind": "org",
      "name": "Osborne Clarke",
      "attrs": {
        "seat": "1050 Bruxelles, Place du Champ de Mars 5"
      }
    }
  ]
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte : DEMISSIONS, NOMINATIONS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS",
      "value": "DEMISSIONS, NOMINATIONS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2025-10-17",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 17/10/2025 - Annexes du Moniteur belge",
      "value": "17/10/2025",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2025-10-15",
      "type": "filing",
      "quote": "D\u00E9pos\u00E9 15-10-2025",
      "value": "15-10-2025",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2025-09-29",
      "type": "notarial_deed",
      "quote": "Ce jour, le vingt-neuf septembre deux mille vingt-cinq. (...) Devant Peter VAN MELKEBEKE, notaire \u00E0 Bruxelles",
      "value": "29/09/2025",
      "object": "e2",
      "subject": "e1"
    },
    {
      "date": "2025-09-29",
      "type": "general_meeting",
      "quote": "Ce jour, le vingt-neuf septembre deux mille vingt-cinq. (...) S\u2019EST REUNIE L\u2019assembl\u00E9e g\u00E9n\u00E9rale extraordinaire",
      "value": "29/09/2025",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "share_cancellation",
      "quote": "l\u2019assembl\u00E9e d\u00E9cide d\u2019annuler les 270 droits de souscription anti-dilution susvis\u00E9s.",
      "value": {
        "count": 270,
        "description": "droits de souscription anti-dilution"
      },
      "object": null,
      "subject": "e1"
    },
    {
      "type": "capital_increase",
      "quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de 2.000.000,00 EUR, pour le porter de 41.994.208,16 EUR \u00E0 43.994.208,16 EUR. (...) \u00E9mission de 181.818 actions privil\u00E9gi\u00E9es de classe D",
      "value": {
        "after": "43.994.208,16 EUR",
        "delta": "2.000.000,00 EUR",
        "amount": 43994208.16,
        "before": "41.994.208,16 EUR",
        "currency": "EUR",
        "share_class": "Actions Privil\u00E9gi\u00E9es de Classe D",
        "shares_issued": 181818,
        "price_per_share": "11,00 EUR"
      },
      "amount": 2000000.0,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": {
        "after": "43.994.208,16 EUR",
        "delta": "2.000.000,00 EUR",
        "before": "41.994.208,16 EUR",
        "share_class": "Actions Privil\u00E9gi\u00E9es de Classe D",
        "shares_issued": 181818,
        "price_per_share": "11,00 EUR"
      }
    },
    {
      "type": "capital",
      "quote": "Le capital est fix\u00E9 \u00E0 quarante trois millions neuf cent nonante-quatre mille deux cent huit euros seize cents (\u20AC 43.994.208,16). Le capital est repr\u00E9sent\u00E9 par six cent trente-six mille trois cent cinquante (636.350) actions",
      "value": {
        "amount": 43994208.16,
        "shares": 636350,
        "currency": "EUR"
      },
      "amount": 43994208.16,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": {
        "amount": "43.994.208,16 EUR",
        "shares": 636350
      }
    },
    {
      "type": "purpose",
      "quote": "ARTICLE TROIS : OBJET ...",
      "value": "La soci\u00E9t\u00E9 a pour objet tant en Belgique qu\u0027\u00E0 l\u0027\u00E9tranger, pour compte propre ou pour compte de tiers ou en participation avec des tiers, le d\u00E9veloppement de nouvelles technologies m\u00E9dicales et notamment mais non exclusivement, la recherche, le d\u00E9veloppement, la fabrication, le brevetage et la commercialisation d\u0027\u00E9l\u00E9ments et de syst\u00E8mes, en ce compris les proc\u00E9dures, les m\u00E9thodes de d\u00E9veloppement et de fabrication, les instruments et le mat\u00E9riel, les mat\u00E9riaux et les produits, les prototypes, les logiciels et programmes techniques recherche, le design, les brevets, les marques, les patentes, les octroi et autres droits de propri\u00E9t\u00E9 industrielle et/ ou intellectuelle, tous li\u00E9s directement ou indirectement aux biotechnologies et aux biomat\u00E9riaux, y compris en particulier les diff\u00E9rentes mati\u00E8res scientifiques, op\u00E9rationnelles, l\u00E9gales et financi\u00E8res. La soci\u00E9t\u00E9 pourra, le cas \u00E9ch\u00E9ant, faire breveter, d\u00E9poser ou autrement faire prot\u00E9ger ses inventions et d\u00E9couvertes au titre de tous types de droits de propri\u00E9t\u00E9 industrielle et/ ou intellectuelle. La soci\u00E9t\u00E9 peut accomplir toutes op\u00E9rations g\u00E9n\u00E9ralement quelconques, commerciales, industrielles, financi\u00E8res, mobili\u00E8res ou immobili\u00E8res, se rapportant directement ou indirectement \u00E0 son objet. Elle peut s\u0027int\u00E9resser par voie d\u0027apport, de souscription, de prise de participation, de fusion, ou toute autre forme d\u0027investissement en titres ou droits mobiliers, dans toutes affaires, entreprises, fondations, associations ou soci\u00E9t\u00E9s ayant un objet identique, analogue, similaire ou connexe, ou qui sont de nature \u00E0 favoriser le d\u00E9veloppement de son entreprise, \u00E0 lui procurer des mati\u00E8res premi\u00E8res ou \u00E0 faciliter l\u0027\u00E9coulement de ses produits. La soci\u00E9t\u00E9 peut pourvoir \u00E0 l\u0027administration, \u00E0 la supervision et au contr\u00F4le de toutes soci\u00E9t\u00E9s li\u00E9es ou avec lesquelles il existe un lien de participation et toutes autres, et consentir tous pr\u00EAts ou garanties \u00E0 celles-ci, sous quelque forme que pour quelque dur\u00E9e que ce soit. Elle peut \u00E9galement exercer les fonctions d\u0027administrateurs ou de liquidateurs dans d\u0027autres soci\u00E9t\u00E9s. De mani\u00E8re g\u00E9n\u00E9rale, la soci\u00E9t\u00E9 peut r\u00E9aliser son objet directement ou indirectement et notamment conclure toute convention d\u0027association, de rationalisation, de collaboration, tout contrat de travail ou d\u0027entreprise, pr\u00EAter son concours financier sous quelque forme que ce soit, ex\u00E9cuter tous travaux et \u00E9tude pour toute entreprise, association ou soci\u00E9t\u00E9 \u00E0 laquelle elle se sera int\u00E9ress\u00E9e ou \u00E0 laquelle elle aura apport\u00E9 son concours financier, vendre, acheter, cautionner, donner \u00E0 bail ou prendre en location tout bien corporel ou incorporel, mobilier ou immobilier, donner \u00E0 bail ou affermer tout ou partie de ses installations, exploitations et son fonds de commerce.",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2025-09-29",
      "type": "officer_resignation",
      "quote": "L\u0027assembl\u00E9e prend acte et accepte la d\u00E9mission des personnes en qualit\u00E9 d\u2019administrateurs suivants, avec effet imm\u00E9diat : - Monsieur VANPARYS Bram Willem Lodewijk Cornelius",
      "value": {
        "date": "2025-09-29",
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e3",
      "_value_raw": {
        "date": "29/09/2025",
        "role": "administrateur"
      }
    },
    {
      "date": "2025-09-29",
      "type": "officer_resignation",
      "quote": "L\u0027assembl\u00E9e prend acte et accepte la d\u00E9mission des personnes en qualit\u00E9 d\u2019administrateurs suivants, avec effet imm\u00E9diat : - Monsieur CARNOT Lionel Marie Sadi",
      "value": {
        "date": "2025-09-29",
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e4",
      "_value_raw": {
        "date": "29/09/2025",
        "role": "administrateur"
      }
    },
    {
      "date": "2025-09-29",
      "type": "officer_resignation",
      "quote": "L\u0027assembl\u00E9e prend acte et accepte la d\u00E9mission des personnes en qualit\u00E9 d\u2019administrateurs suivants, avec effet imm\u00E9diat : - Monsieur MARTIN Wax",
      "value": {
        "date": "2025-09-29",
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e5",
      "_value_raw": {
        "date": "29/09/2025",
        "role": "administrateur"
      }
    },
    {
      "type": "officer_discharge",
      "quote": "L\u0027assembl\u00E9e les remercie express\u00E9ment pour les services rendus et leur donne d\u00E9charge provisoire pour l\u0027exercice de leurs mandats d\u0027administrateur jusqu\u0027\u00E0 ce jour.",
      "value": {
        "role": null
      },
      "object": "e1",
      "subject": "e3",
      "_value_raw": "d\u00E9charge provisoire"
    },
    {
      "type": "officer_discharge",
      "quote": "L\u0027assembl\u00E9e les remercie express\u00E9ment pour les services rendus et leur donne d\u00E9charge provisoire pour l\u0027exercice de leurs mandats d\u0027administrateur jusqu\u0027\u00E0 ce jour.",
      "value": {
        "role": null
      },
      "object": "e1",
      "subject": "e4",
      "_value_raw": "d\u00E9charge provisoire"
    },
    {
      "type": "officer_discharge",
      "quote": "L\u0027assembl\u00E9e les remercie express\u00E9ment pour les services rendus et leur donne d\u00E9charge provisoire pour l\u0027exercice de leurs mandats d\u0027administrateur jusqu\u0027\u00E0 ce jour.",
      "value": {
        "role": null
      },
      "object": "e1",
      "subject": "e5",
      "_value_raw": "d\u00E9charge provisoire"
    },
    {
      "date": "2024-01-01",
      "type": "officer_appointment",
      "quote": "l\u2019assembl\u00E9e d\u00E9cide de nommer et de ratifier la nomination de la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e MV Lifesciences ... en qualit\u00E9 d\u2019administrateur de la Soci\u00E9t\u00E9 avec effet \u00E0 compter de l\u2019assembl\u00E9e g\u00E9n\u00E9rale ordinaire de la soci\u00E9t\u00E9 de 2024",
      "value": {
        "role": "administrateur",
        "term": "jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u0027an 2028",
        "start_date": "2024-01-01"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "note": "nomination ratifi\u00E9e avec effet r\u00E9troactif \u00E0 l\u0027AGO 2024",
        "role": "administrateur",
        "term": "jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u0027an 2028",
        "start_date": "2024-01-01"
      }
    },
    {
      "type": "permanent_representative",
      "quote": "repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent, Monsieur VANBRABANT Michel",
      "value": null,
      "object": "e6",
      "subject": "e7"
    },
    {
      "type": "officer_appointment",
      "quote": "MV Lifesciences SRL, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent, Monsieur Michel Vanbrabant, qui poursuit son mandat d\u2019administrateur d\u00E9l\u00E9gu\u00E9",
      "value": {
        "role": "administrateur d\u00E9l\u00E9gu\u00E9"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "note": "poursuite du mandat",
        "role": "administrateur d\u00E9l\u00E9gu\u00E9"
      }
    },
    {
      "type": "officer_appointment",
      "quote": "En cons\u00E9quence, le conseil d\u2019administration de la Soci\u00E9t\u00E9 est compos\u00E9 comme suit : (...) Monsieur Richard L. Beckman",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e8"
    },
    {
      "type": "officer_appointment",
      "quote": "En cons\u00E9quence, le conseil d\u2019administration de la Soci\u00E9t\u00E9 est compos\u00E9 comme suit : (...) Monsieur Marc Nolet de Brauwere van Steeland",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e9"
    },
    {
      "type": "officer_appointment",
      "quote": "En cons\u00E9quence, le conseil d\u2019administration de la Soci\u00E9t\u00E9 est compos\u00E9 comme suit : (...) La soci\u00E9t\u00E9 anonyme Capricorn Partners",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e10"
    },
    {
      "type": "permanent_representative",
      "quote": "repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Monsieur Filip Pintelon",
      "value": null,
      "object": "e10",
      "subject": "e11"
    },
    {
      "type": "officer_appointment",
      "quote": "En cons\u00E9quence, le conseil d\u2019administration de la Soci\u00E9t\u00E9 est compos\u00E9 comme suit : (...) Monsieur Bruno Holthof",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e12"
    },
    {
      "type": "officer_appointment",
      "quote": "En cons\u00E9quence, le conseil d\u2019administration de la Soci\u00E9t\u00E9 est compos\u00E9 comme suit : (...) Monsieur David Guyer",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e13"
    },
    {
      "type": "power_of_attorney",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de conf\u00E9rer tous pouvoirs \u00E0 ... Madame Caroline Daout, avocate, Madame Virginie Lescot, avocate, Madame Stefania Sacuiu, avocate, ou tout autre avocat du cabinet d\u2019avocats \u0022Van Bael \u0026 Bellis\u0022 ... afin (a) d\u2019ex\u00E9cuter toutes les formalit\u00E9s n\u00E9cessaires ... (b) de mettre \u00E0 jour le registre des actions ... (c) de faire en g\u00E9n\u00E9ral tout ce qui est n\u00E9cessaire ou utile",
      "value": "ex\u00E9cuter toutes les formalit\u00E9s n\u00E9cessaires aupr\u00E8s de toute administration comp\u00E9tente ... mise \u00E0 jour de l\u0027inscription ... registre des actions ...",
      "object": "e1",
      "subject": "e14"
    }
  ],
  "act_meta": {
    "outcome": "review",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 45830,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0828.058.712",
      "kind": "company",
      "name": "ISTAR MEDICAL",
      "attrs": {
        "seat": "1300 Wavre, Avenue Sabin 6",
        "legal_form": "Soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Peter VAN MELKEBEKE",
      "attrs": {
        "address": "1000 Bruxelles, Avenue Lloyd George 11"
      }
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "VANPARYS Bram Willem Lodewijk Cornelius",
      "attrs": {
        "birth_date": "1980-11-12",
        "birth_place": "Furnes"
      }
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "person",
      "name": "CARNOT Lionel Marie Sadi",
      "attrs": {
        "birth_date": "1967-06-18",
        "birth_place": "Cologny (Suisse)"
      }
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "MARTIN Wax",
      "attrs": {
        "birth_date": "1951-08-17",
        "birth_place": "New-York (Etats-Unis d\u2019Am\u00E9rique)"
      }
    },
    {
      "id": "e6",
      "kbo": "0781.705.776",
      "kind": "company",
      "name": "MV Lifesciences",
      "attrs": {
        "seat": "rue de Genval 22, 1331 Rosi\u00E8res (Belgique)",
        "legal_form": "soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
      }
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "VANBRABANT Michel",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "Richard L. Beckman",
      "attrs": {}
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Marc Nolet de Brauwere van Steeland",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "company",
      "name": "Capricorn Partners",
      "attrs": {
        "legal_form": "soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Filip Pintelon",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": null,
      "kind": "person",
      "name": "Bruno Holthof",
      "attrs": {}
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "David Guyer",
      "attrs": {}
    },
    {
      "id": "e14",
      "kbo": null,
      "kind": "org",
      "name": "Van Bael \u0026 Bellis",
      "attrs": {
        "address": "chauss\u00E9e de La Hulpe 166 \u00E0 1170 Bruxelles"
      }
    }
  ]
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte : DEMISSIONS, NOMINATIONS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS",
      "value": "DEMISSIONS, NOMINATIONS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2022-02-23",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 23/02/2022 - Annexes du Moniteur belge",
      "value": "23/02/2022",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2022-02-21",
      "type": "filing",
      "quote": "D\u00E9pos\u00E9 21-02-2022",
      "value": "21-02-2022",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2022-02-16",
      "type": "notarial_deed",
      "quote": "Ce jour, le seize f\u00E9vrier deux mille vingt-deux. (...) Devant Peter VAN MELKEBEKE, notaire",
      "value": "16/02/2022",
      "object": "e2",
      "subject": "e1"
    },
    {
      "date": "2022-02-16",
      "type": "general_meeting",
      "quote": "Ce jour, le seize f\u00E9vrier deux mille vingt-deux. (...) S\u0027EST REUNIE L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire",
      "value": "16/02/2022",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2022-02-10",
      "type": "board_meeting",
      "quote": "proc\u00E8s-verbal du conseil d\u0027administration en date du 10 f\u00E9vrier 2022",
      "value": "10/02/2022",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "capital_increase",
      "quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de 76.868,85 EUR, pour le porter de 696.570,53 EUR \u00E0 773.439,38 EUR, par l\u0027\u00E9mission de 24.998 actions privil\u00E9gi\u00E9es de classe C... par l\u0027apport d\u0027une cr\u00E9ance... que Capricorn Health-Tech Fund... d\u00E9tiennent conjointement",
      "value": {
        "after": "773.439,38 EUR",
        "delta": "76.868,85 EUR",
        "amount": 773439.38,
        "before": "696.570,53 EUR",
        "method": "apport en nature",
        "currency": "EUR",
        "subscribers": [
          "e12",
          "e13",
          "e14",
          "e15",
          "e16",
          "e17",
          "e18",
          "e19",
          "e20",
          "e21"
        ],
        "shares_issued": "24.998 actions privil\u00E9gi\u00E9es de classe C"
      },
      "amount": 76868.85,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": {
        "after": "773.439,38 EUR",
        "delta": "76.868,85 EUR",
        "before": "696.570,53 EUR",
        "method": "apport en nature",
        "subscribers": [
          "e12",
          "e13",
          "e14",
          "e15",
          "e16",
          "e17",
          "e18",
          "e19",
          "e20",
          "e21"
        ],
        "shares_issued": "24.998 actions privil\u00E9gi\u00E9es de classe C"
      }
    },
    {
      "type": "capital_increase",
      "quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de 156.028,58 EUR, pour le porter de 773.439,38 EUR \u00E0 929.467,96 EUR... par apport en num\u00E9raire et par l\u0027\u00E9mission de 50.741 nouvelles actions privil\u00E9gi\u00E9es de classe C",
      "value": {
        "after": "929.467,96 EUR",
        "delta": "156.028,58 EUR",
        "amount": 929467.96,
        "before": "773.439,38 EUR",
        "method": "apport en num\u00E9raire",
        "currency": "EUR",
        "shares_issued": "50.741 nouvelles actions privil\u00E9gi\u00E9es de classe C",
        "price_per_share": "200,00 EUR"
      },
      "amount": 156028.58,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": {
        "after": "929.467,96 EUR",
        "delta": "156.028,58 EUR",
        "before": "773.439,38 EUR",
        "method": "apport en num\u00E9raire",
        "shares_issued": "50.741 nouvelles actions privil\u00E9gi\u00E9es de classe C",
        "price_per_share": "200,00 EUR"
      }
    },
    {
      "type": "capital_increase",
      "quote": "Le capital est d\u00E8s lors augment\u00E9 \u00E0 concurrence de 1.731,22 EUR et port\u00E9 de 929.467,96 EUR \u00E0 931.199,18 EUR... par l\u0027\u00E9mission de 563 nouvelles actions ordinaires",
      "value": {
        "after": "931.199,18 EUR",
        "delta": "1.731,22 EUR",
        "amount": 931199.18,
        "before": "929.467,96 EUR",
        "method": "exercice de droits de souscription",
        "currency": "EUR",
        "shares_issued": "563 nouvelles actions ordinaires",
        "price_per_share": "52,00 EUR"
      },
      "amount": 1731.22,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": {
        "after": "931.199,18 EUR",
        "delta": "1.731,22 EUR",
        "before": "929.467,96 EUR",
        "method": "exercice de droits de souscription",
        "shares_issued": "563 nouvelles actions ordinaires",
        "price_per_share": "52,00 EUR"
      }
    },
    {
      "type": "capital",
      "quote": "Le capital est fix\u00E9 \u00E0 neuf cent trente et un mille cent nonante-neuf euros dix-huit cents (\u20AC 931.199,18).",
      "value": {
        "currency": "EUR"
      },
      "amount": 931199.18,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": "931.199,18 EUR"
    },
    {
      "date": "2022-02-16",
      "type": "officer_resignation",
      "quote": "L\u0027assembl\u00E9e prend connaissance et accepte la d\u00E9mission de la personne suivante en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, et ce \u00E0 partir de ce jour : - New Breath SRL",
      "value": {
        "date": "2022-02-16",
        "role": "administrateur"
      },
      "object": null,
      "subject": "e6",
      "_value_raw": {
        "date": "16/02/2022",
        "role": "administrateur"
      }
    },
    {
      "date": "2022-02-16",
      "type": "officer_resignation",
      "quote": "Le conseil d\u0027administration prend connaissance de la d\u00E9mission de New Breath SRL... en qualit\u00E9 d\u0027administrateur-d\u00E9l\u00E9gu\u00E9 et CEO de la Soci\u00E9t\u00E9 et ce, avec effet au 16 f\u00E9vrier 2022.",
      "value": {
        "date": "2022-02-16",
        "role": "administrateur-d\u00E9l\u00E9gu\u00E9 et CEO"
      },
      "object": null,
      "subject": "e6",
      "_value_raw": {
        "date": "16/02/2022",
        "role": "administrateur-d\u00E9l\u00E9gu\u00E9 et CEO"
      }
    },
    {
      "date": "2022-02-16",
      "type": "officer_appointment",
      "quote": "L\u0027assembl\u00E9e d\u00E9cide de nommer la personne suivante en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, et ce \u00E0 partir de ce jour : - MV Lifesciences SRL... Son mandat prend fin \u00E0 l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire qui se tiendra en 2024.",
      "value": {
        "role": "administrateur",
        "term": "\u00E0 l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire qui se tiendra en 2024",
        "start_date": "2022-02-16"
      },
      "object": null,
      "subject": "e8",
      "_value_raw": {
        "role": "administrateur",
        "term": "\u00E0 l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire qui se tiendra en 2024",
        "start_date": "16/02/2022"
      }
    },
    {
      "date": "2022-02-16",
      "type": "officer_appointment",
      "quote": "Le conseil d\u0027administration d\u00E9cide de nommer, \u00E0 compter du 16 f\u00E9vrier 2022, MV Lifesciences SRL... en qualit\u00E9 d\u0027administrateur-d\u00E9l\u00E9gu\u00E9 et CEO de la Soci\u00E9t\u00E9",
      "value": {
        "role": "administrateur-d\u00E9l\u00E9gu\u00E9 et CEO",
        "term": "jusqu\u0027\u00E0 la fin de son mandat d\u0027administrateur, ou du renouvellement de ce dernier, ou jusqu\u0027\u00E0 ce que le conseil d\u0027administration en d\u00E9cide autrement",
        "start_date": "2022-02-16"
      },
      "object": null,
      "subject": "e8",
      "_value_raw": {
        "role": "administrateur-d\u00E9l\u00E9gu\u00E9 et CEO",
        "term": "jusqu\u0027\u00E0 la fin de son mandat d\u0027administrateur, ou du renouvellement de ce dernier, ou jusqu\u0027\u00E0 ce que le conseil d\u0027administration en d\u00E9cide autrement",
        "start_date": "16/02/2022"
      }
    },
    {
      "type": "permanent_representative",
      "quote": "MV Lifesciences SRL... dont Monsieur Michel Vanbrabant est le repr\u00E9sentant permanant",
      "value": null,
      "object": "e8",
      "subject": "e7"
    },
    {
      "type": "permanent_representative",
      "quote": "New Breath SRL... dont Monsieur Michel Vanbrabant est le repr\u00E9sentant permanant",
      "value": null,
      "object": "e6",
      "subject": "e7"
    },
    {
      "type": "mandate_compensation",
      "quote": "Le mandat ainsi conf\u00E9r\u00E9 [administrateur-d\u00E9l\u00E9gu\u00E9] est r\u00E9mun\u00E9.",
      "value": "r\u00E9mun\u00E9r\u00E9",
      "object": null,
      "subject": "e8"
    },
    {
      "type": "mandate_compensation",
      "quote": "Son mandat [administrateur] est non r\u00E9mun\u00E9r\u00E9, sauf d\u00E9cision contraire de l\u0027assembl\u00E9e g\u00E9n\u00E9rale.",
      "value": "non r\u00E9mun\u00E9r\u00E9",
      "object": null,
      "subject": "e8"
    },
    {
      "type": "statute_amendment",
      "quote": "TREIZIEME RESOLUTION : Modification des articles 5.1. et 5.2. des statuts.",
      "value": "Modification des articles 5.1 et 5.2 (capital et actions)",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "filing_representative",
      "quote": "L\u0027assembl\u00E9e conf\u00E8re tous pouvoirs \u00E0 Maxime Violon, Caroline Daout ou tout autre avocat ou collaborateur du cabinet d\u0027avocats DLA Piper UK LLP... afin d\u0027assurer les formalit\u00E9s aupr\u00E8s d\u0027un guichet d\u0027entreprise... et, le cas \u00E9ch\u00E9ant, aupr\u00E8s de l\u0027Administration de la Taxe sur la Valeur Ajout\u00E9e.",
      "value": "formalit\u00E9s aupr\u00E8s d\u0027un guichet d\u0027entreprise (BCE) et TVA",
      "object": "e1",
      "subject": "e9"
    },
    {
      "type": "bank_account",
      "quote": "sur un compte sp\u00E9cial num\u00E9ro BE51 0019 2313 7962 tel qu\u0027il r\u00E9sulte d\u0027une attestation bancaire d\u00E9livr\u00E9e par BNP Paribas Fortis",
      "value": "BE51 0019 2313 7962",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "preemptive_rights_waiver",
      "quote": "L\u0027assembl\u00E9e d\u00E9cide de supprimer le droit de pr\u00E9f\u00E9rence des actionnaires existants, conform\u00E9ment aux articles 7:191 et 7:193 du Code des soci\u00E9t\u00E9s et des associations, en faveur des souscripteurs \u00E0 l\u0027augmentation du capital en num\u00E9raire.",
      "value": "en faveur des souscripteurs \u00E0 l\u0027augmentation du capital en num\u00E9raire",
      "object": null,
      "subject": "e1"
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 24066,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0828.058.712",
      "kind": "company",
      "name": "ISTAR MEDICAL",
      "attrs": {
        "seat": "1300 Wavre, avenue Sabin 6",
        "legal_form": "Soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Peter VAN MELKEBEKE",
      "attrs": {
        "address": "Bruxelles, avenue Lloyd George 11"
      }
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "org",
      "name": "Berquin Notaires",
      "attrs": {
        "seat": "Bruxelles, avenue Lloyd George 11"
      }
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "org",
      "name": "PwC Reviseurs d\u0027Entreprises SRL",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "M\u00E9lanie Adorante",
      "attrs": {
        "role": "R\u00E9viseur d\u0027Entreprises"
      }
    },
    {
      "id": "e6",
      "kbo": "0832.578.021",
      "kind": "company",
      "name": "New Breath SRL",
      "attrs": {
        "seat": "1331 Rosi\u00E8res, 22 rue de Genval"
      }
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "Michel Vanbrabant",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": "0781.705.776",
      "kind": "company",
      "name": "MV Lifesciences SRL",
      "attrs": {
        "seat": "1331 Rosi\u00E8res, 22 rue de Genval, Belgique",
        "status": "soci\u00E9t\u00E9 \u00E0 constituer"
      }
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "org",
      "name": "DLA Piper UK LLP",
      "attrs": {
        "address": "1000 Bruxelles, Rue aux Laines 70"
      }
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "person",
      "name": "Maxime Violon",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Caroline Daout",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": null,
      "kind": "company",
      "name": "Capricorn Health-Tech Fund, S.R.I.W.",
      "attrs": {}
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "company",
      "name": "Chagral Invest, Fonds Europ\u00E9en des Mat\u00E9riaux, Financi\u00E8re Spin-off Luxembourgeoise",
      "attrs": {}
    },
    {
      "id": "e14",
      "kbo": null,
      "kind": "company",
      "name": "NAMUR INVEST PREFACE",
      "attrs": {}
    },
    {
      "id": "e15",
      "kbo": null,
      "kind": "person",
      "name": "Christophe Pagnoulle",
      "attrs": {}
    },
    {
      "id": "e16",
      "kbo": null,
      "kind": "person",
      "name": "Christian Homsy",
      "attrs": {}
    },
    {
      "id": "e17",
      "kbo": null,
      "kind": "person",
      "name": "Michel Lussier",
      "attrs": {}
    },
    {
      "id": "e18",
      "kbo": null,
      "kind": "company",
      "name": "GIMV",
      "attrs": {}
    },
    {
      "id": "e19",
      "kbo": null,
      "kind": "company",
      "name": "LSP HEF 2 HOLDING",
      "attrs": {}
    },
    {
      "id": "e20",
      "kbo": null,
      "kind": "company",
      "name": "EARLYBIRD HEALTH GMBH \u0026 CO. BETEILIGUNGS KG",
      "attrs": {}
    },
    {
      "id": "e21",
      "kbo": null,
      "kind": "company",
      "name": "BNP PARIBAS FORTIS PRIVATE EQUITY BELGIUM",
      "attrs": {}
    }
  ]
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte : CONSTITUTION",
      "value": "CONSTITUTION",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2022-02-10",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 10/02/2022 - Annexes du Moniteur belge",
      "value": "10/02/2022",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2022-02-08",
      "type": "filing",
      "quote": "D\u00E9pos\u00E9 08-02-2022",
      "value": "08-02-2022",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2022-02-07",
      "type": "notarial_deed",
      "quote": "Extrait de l\u2019acte constitutif re\u00E7u par Beno\u00EEt COLMANT... en date du 07.02.2022",
      "value": "07.02.2022",
      "object": "e4",
      "subject": "e1"
    },
    {
      "date": "2022-02-07",
      "type": "incorporation",
      "quote": "Le comparant requiert le notaire soussign\u00E9 d\u2019acter qu\u2019il constitue une soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e... en date du 07.02.2022",
      "value": "07.02.2022",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "founder",
      "quote": "FONDATEUR Monsieur VANBRABANT Michel Roger Emmanuel",
      "value": null,
      "object": "e1",
      "subject": "e2"
    },
    {
      "type": "founding_capital",
      "quote": "aux capitaux propres de d\u00E9part de vingt mille euros (\u20AC 20.000,00)... Le comparant d\u00E9clare souscrire les 200 actions, en esp\u00E8ces, au prix de 100 euros chacune",
      "value": {
        "amount": 20000.0,
        "shares": 200,
        "currency": "EUR",
        "subscribers": [
          "e2"
        ],
        "price_per_share": "100"
      },
      "amount": 20000.0,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": {
        "amount": "20000.00",
        "shares": 200,
        "currency": "EUR",
        "subscribers": [
          "e2"
        ],
        "price_per_share": "100"
      }
    },
    {
      "date": "2022-02-03",
      "type": "bank_account",
      "quote": "d\u00E9pos\u00E9 sur un compte sp\u00E9cial ouvert au nom de la soci\u00E9t\u00E9 en formation aupr\u00E8s de la banque BNP PARIBAS FORTIS... Une attestation de ladite banque en date du 03 f\u00E9vrier 2022",
      "value": {
        "date": "03 f\u00E9vrier 2022",
        "amount": "20000.00",
        "currency": "EUR"
      },
      "object": "e6",
      "subject": "e1"
    },
    {
      "type": "purpose",
      "quote": "OBJET La soci\u00E9t\u00E9 a pour objet...",
      "value": "La soci\u00E9t\u00E9 a pour objet, tant en Belgique qu\u2019\u00E0 l\u2019\u00E9tranger, pour compte propre ou pour compte de tiers ou en participation avec des tiers : 1. de traiter, dans leur acceptation la plus large, toutes les op\u00E9rations rentrant dans: 1. le domaine du conseil en d\u00E9veloppement organisationnel et en strat\u00E9gie, et plus g\u00E9n\u00E9ralement de l\u2019activit\u00E9 : de conseillers d\u2019entreprises et d\u2019organisation, et d\u2019experts techniques; 2. le domaine d\u2019autres activit\u00E9s dont le concours serait n\u00E9cessaire ou utile \u00E0 son objet principal; 2. d\u2019entreprendre tous travaux d\u2019\u00E9tudes et de recherches commerciales, industrielles, techniques et scientifiques... 3. le service de consultance, l\u2019assistance technique, la gestion et la direction... La soci\u00E9t\u00E9 a \u00E9galement pour objet... 1. la recherche, le d\u00E9veloppement et le conseil en mati\u00E8re financi\u00E8re, marketing, commercial, ou de gestion sociale; 2. l\u2019assistance des entreprises et de particuliers... La soci\u00E9t\u00E9 peut notamment : pr\u00E9parer des \u00E9tudes... assister des entreprises... r\u00E9diger de rapports... organiser la conduite d\u2019\u00E9tudes... ex\u00E9cuter des travaux de secr\u00E9tariat... ex\u00E9cuter les activit\u00E9s de maintien et l\u2019entretien de biens immobiliers... ex\u00E9cuter toutes op\u00E9rations qui ont directement ou indirectement un lien avec la valorisation de biens immeubles... la cr\u00E9ation, la promotion, la gestion et l\u2019organisation de tous types d\u2019\u00E9v\u00E8nements... 1. l\u2019achat et la vente, l\u2019importation et l\u2019exportation... 2. l\u0027acceptation et l\u0027exercice de mandats... La soci\u00E9t\u00E9 peut notamment : louer et souslouer tous droits r\u00E9els... conduire toutes op\u00E9rations et \u00E9tudes ayant trait aux biens immeubles... ex\u00E9cuter toutes op\u00E9rations financi\u00E8res... hypoth\u00E9quer tous biens meubles et immeubles...",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2022-02-07",
      "type": "officer_appointment",
      "quote": "Est nomm\u00E9 \u00E0 la fonction d\u2019administrateur pour un terme illimit\u00E9 : Monsieur Michel Vanbrabant, qui accepte.",
      "value": {
        "role": "administrateur",
        "term": "illimit\u00E9",
        "start_date": "2022-02-07"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "administrateur",
        "term": "illimit\u00E9",
        "start_date": "07.02.2022"
      }
    },
    {
      "type": "mandate_compensation",
      "quote": "Son mandat est r\u00E9mun\u00E9r\u00E9.",
      "value": "r\u00E9mun\u00E9r\u00E9",
      "object": "e1",
      "subject": "e2"
    },
    {
      "type": "first_fiscal_year",
      "quote": "Le premier exercice social d\u00E9butera le jour du d\u00E9p\u00F4t au greffe d\u2019un extrait du pr\u00E9sent acte et finira le 31 d\u00E9cembre 2022.",
      "value": {
        "end": "31 d\u00E9cembre 2022",
        "start": "08-02-2022"
      },
      "object": null,
      "subject": "e1"
    },
    {
      "type": "power_of_attorney",
      "quote": "La soci\u00E9t\u00E9 CMD Partners de Watermael-Boitsfort, ou toute autre personne d\u00E9sign\u00E9e par elle ou le fondateur, est d\u00E9sign\u00E9e en qualit\u00E9 de mandataire ad hoc de la soci\u00E9t\u00E9...",
      "value": {
        "scope": "mandataire ad hoc... signer tous documents et de faire toutes les d\u00E9clarations n\u00E9cessaires et toutes formalit\u00E9s d\u2019inscription aupr\u00E8s de toutes administrations publiques et priv\u00E9es (Banque-Carrefour des Entreprises et Taxe sur la Valeur Ajout\u00E9e compris)... prendre tous engagements au nom de la soci\u00E9t\u00E9"
      },
      "object": "e1",
      "subject": "e5"
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 25911,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0781.705.776",
      "kind": "company",
      "name": "MV Lifesciences",
      "attrs": {
        "seat": "1331 Rixensart (Rosi\u00E8res), Rue de Genval 22",
        "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "VANBRABANT Michel Roger Emmanuel",
      "attrs": {
        "address": "1331 Rixensart (Rosi\u00E8res), Rue de Genval 22"
      }
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "org",
      "name": "NICAISE, COLMANT ET LIGOT",
      "attrs": {
        "seat": "1390 Grez-Doiceau, All\u00E9e du Bois de Bercuit, 14",
        "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
      }
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "person",
      "name": "Beno\u00EEt COLMANT",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "company",
      "name": "CMD Partners",
      "attrs": {
        "seat": "Watermael-Boitsfort"
      }
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "org",
      "name": "BNP PARIBAS FORTIS",
      "attrs": {}
    }
  ]
}